Healthcare & Life Sciences
Anaveon
Switzerlandanaveon.com
Anaveon is a Healthcare & Life Sciences startup based in Switzerland, most recent round Series B, 2 tracked investors.
activeseries-b
series-b
Stage
2020
Founded
2
Investors
About Anaveon
Based in Switzerland, Anaveon is a startup founded in 2020. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Anaveon is a clinical-stage biopharmaceutical company developing antibody and protein-based biologics to modulate the immune system for autoimmune diseases and oncology. Its lead programs include ANV200, a PD-1–targeting T‑cell depleting antibody for autoimmune indications, and ANV600, in Phase I/II for solid tumours.
Explore Anaveon's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.